A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome

NCT06518876 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

POEMS Syndrome

Interventions

BIOLOGICAL: KQ-2003 CAR T-cells

Sponsor

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.